Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Volasertib

EU orphan designation number: EU/3/14/1255   
Active ingredient: Volasertib
Indication: Treatment of acute myeloid leukaemia
Sponsor: Boehringer Ingelheim International GmbH
Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/03/2014 Orphan designation EMA/OD/181/13 (2014)2113 of 26/03/2014